UBS O'Connor’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-68,014
| Closed | -$466K | – | 426 |
|
|
2023
Q3 | $466K | Sell |
68,014
-5,000
| -7% | -$34.3K | 0.01% | 392 |
|
|
2023
Q2 | $757K | Sell |
73,014
-10,664
| -13% | -$111K | 0.02% | 402 |
|
|
2023
Q1 | $677K | Buy |
+83,678
| New | +$677K | 0.02% | 433 |
|
|
2022
Q4 | – | Sell |
-113,426
| Closed | -$1.79M | – | 16 |
|
|
2022
Q3 | $1.79M | Hold |
113,426
| – | – | 0.02% | 650 |
|
|
2022
Q2 | $1.58M | Buy |
+113,426
| New | +$1.58M | 0.02% | 692 |
|